I was cruising around looking for up to date information on CFS and Fibro Treatment. I am sure many of you are already aware of both the Marshall protocol and the Montoya study. This is the latest thing I found on Montoya.
This was posted on December 20 2008.
Hello, I am a physician in San Francisco (The House Doctor) and have been conducting research for one on my patients with CFS before initiating treatment. In doing so, I have come across some interesting findings and have drawn a few conclusions:
Dr. Lerner of Michigan in his studies has concluded that there are three subtypes of viral infections causing CFS: 1. those with EBV alone 2. those with CMV alone and 3. those with both EBV and CMV.
Further, he has found that those with only EBV respond well to treatment with Valtrex. However, those with CMV do not respond to Valtrex and instead require Valcyte (actually IV gangicyclovir, but for blogging purposes Valcyte is easier to type), and treats those with concomitant EBV and CMV infections with both medications.
Dr. Montoya of Stanford in his studies, however, does not seem to take into account whether or not active CMV infection is present and instead uses the criterion that one must show evidence of both active EBV and HHV-6 infections. He has had excellent results treating with Valcyte alone.
This leads me to several conclusions regarding the treatment of CFS:
1. Although there are no formal studies showing it, Valcyte seems to show good antiviral activity against all three viruses (EBV, CMV, HHV-6).
2. If one shows evidence of active infection with EBV alone, then treatment with Valtrex would be preferable to treatment with Valcyte as there are far fewer toxicities associated with Valtrex.
3. If one shows evidence of active infection with CMV or HHV-6 (whether or not active EBV infection is present), then Valcyte seems to be the drug of choice. Additionally, Dr. Lerner could probably use Valcyte alone in his patients infected with both EBV+CMV.
4. Dr. Montoya should also be testing for active CMV infection (perhaps he does and I am not aware). Even if Dr. Montoya does not officially include this data in his current study, it may prove to be very valuable data for future research and retrospective analysis.
Fibromyalgia, Chronic Fatigue, IBS, Diverticulitis, Costocondritis, Thorasic Degeneration, Mild Hypertrophic Cardiomyopathy, Mild Hilar Lymphodenopathy, Depression, Anxiety. Dyspnea. Disequilibrium.
Klonopin, Percocet, Baclofen, Ibuprofen, Valerian, Greens Plus, Magnesium, Vitamin C, COQ 10, B Complex, Niacinamide, Glucosomine, Condrotin, MSM, L-Carnitine, D-Ribose.